Silo Pharma, Inc.
SILO
$1.06
-$0.0148-1.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Cost of Revenue | 1.69% | -1.67% | -1.67% | -1.67% | -1.67% |
| Gross Profit | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A Expenses | -19.80% | -23.86% | -20.08% | 10.99% | 26.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.64% | -8.40% | -16.89% | -1.43% | 5.59% |
| Operating Income | -22.05% | 8.54% | 17.16% | 1.46% | -5.70% |
| Income Before Tax | -20.98% | 12.46% | 24.53% | 16.25% | 7.07% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.98% | 12.46% | 24.53% | 16.25% | 7.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.70% | 10.82% | 23.01% | 14.60% | 5.31% |
| EBIT | -22.05% | 8.54% | 17.16% | 1.46% | -5.70% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 1.22% | 12.15% | 27.47% | 26.93% | 27.34% |
| Normalized Basic EPS | -5.55% | 10.41% | 25.79% | 21.27% | 24.27% |
| EPS Diluted | 1.44% | 12.32% | 27.58% | 27.05% | 27.16% |
| Normalized Diluted EPS | -5.55% | 10.41% | 25.79% | 21.27% | 24.27% |
| Average Basic Shares Outstanding | 17.68% | 5.59% | 5.39% | 18.28% | 36.82% |
| Average Diluted Shares Outstanding | 17.68% | 5.59% | 5.39% | 18.28% | 36.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |